Lung Cancer Research Foundation

October 5, 2015

Potential target for lung cancer therapy

The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies.

By Leigh MacMillan